Results 21 to 30 of about 309,126 (317)

Placental growth factor expression is required for bone marrow endothelial cell support of primitive murine hematopoietic cells. [PDF]

PLoS ONE, 2013
Two distinct microenvironmental niches that regulate hematopoietic stem/progenitor cell physiology in the adult bone marrow have been proposed; the endosteal and the vascular niche.
Xiaoying Zhou, Lora W Barsky, Gregor B Adams   +2 more
doaj   +1 more source

Loss of quiescence and impaired function of CD34+/CD38low cells one year following autologous stem cell transplantation

Haematologica, 2013
Patients who have undergone autologous stem cell transplantation are subsequently more susceptible to chemotherapy-induced bone marrow toxicity. In the present study, bone marrow primitive progenitor cells were examined one year after autologous stem ...
Carolien M. Woolthuis, Annet Z. Brouwers-Vos, Gerwin Huls, Joost Th. M. de Wolf, Jan Jacob Schuringa, Edo Vellenga   +5 more
doaj   +1 more source

Generation of osteoinductive grafts by three-dimensional perfusion culture of human bone marrow cells into porous ceramic scaffolds [PDF]

, 2005
The main aims of this thesis were (i) to identify and develop a system that could be reproducibly used to streamline manufacture of osteoinductive grafts based on human bone marrow stromal cells (BMSC) in the context of regenerative medicine, (ii) to ...
Braccini, Alessandra
core   +1 more source

MOBILIZATION OF STEM CELLS AFTER LIVER TRANSPLANTATION AND RESECTION

Вестник трансплантологии и искусственных органов, 2010
The review article analyses the published literature for mobilization of CD34/CD45 positive bone marrow cells into peripheral blood after liver injury.
R. M. Kurabekova, O. M. Tsirulnikova, O. P. Shevchenko   +2 more
doaj   +1 more source

MicroRNA changes of bone marrow-derived mesenchymal stem cells differentiated into neuronal-like cells by Schwann cell-conditioned medium

Neural Regeneration Research, 2019
Bone marrow-derived mesenchymal stem cells differentiate into neurons under the induction of Schwann cells. However, key microRNAs and related pathways for differentiation remain unclear.
Zhi-Jian Wei, Bao-You Fan, Yang Liu, Han Ding, Hao-Shuai Tang, Da-Yu Pan, Jia-Xiao Shi, Peng-Yuan Zheng, Hong-Yu Shi, Heng Wu, Ang Li, Shi-Qing Feng   +11 more
doaj   +1 more source

Stem cells in the ovary [PDF]

, 2009
For decades, scientists have thought that female mammals are born with a lifetime supply of oocytes in the ovary, irreversibly destined to decline after birth.
Tomaszczuk-Kossowska, Katarzyna
core   +1 more source

Prospective isolation of human bone marrow stromal cell subsets: a comparative study between Stro-1-, CD146- and CD105-enriched populations

, 2014
Stro-1 has proved an efficacious marker for enrichment of skeletal stem and progenitor cells although isolated populations remain heterogeneous, exhibiting variable colony-forming efficiency and osteogenic differentiation potential. The emerging findings
Greenhough, Joanna, Oreffo, Richard, David Gothard, Joanna Greenhough, Ralph, Esther, Gothard, David, Esther Ralph, Richard OC Oreffo   +7 more
core   +1 more source

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

, 2004
Background— Cell therapy with bone marrow–derived stem/progenitor cells is a novel option for improving neovascularization and cardiac function in ischemic heart disease.
Dimmeler, S, Heeschen, C, Aicher, A, Martin, H, Assmus, B, Lehmann, R, Walter, DH, Zeiher, AM, Honold, J   +8 more
core   +1 more source

VEGF-expressing mesenchymal stem cells for improved angiogenesis in regenerative medicine : a bone tissue engineering approach [PDF]

, 2011
Rapid vascularization of tissue-engineered grafts is a major bottleneck in the development of regenerative medicine approaches. In order to overcome this limitation, we aimed to develop a bone tissue engineering strategy combining cell therapy with pro ...
Helmrich, Uta
core   +1 more source

Nutritional status indices on the prognosis of patients with relapsed and refractory multiple myeloma treated with CAR-T cell immunotherapy

Frontiers in Nutrition
Background aimsChimeric antigen receptor (CAR) T-cell therapy shows remarkable efficacy against relapsed/refractory multiple myeloma (R/R MM). Nutritional status, assessed by objective indices like the Controlling Nutritional Status (CONUT) and ...
Peng Xu, Peng Xu, Peng Xu, Yang Liu, Yang Liu, Yang Liu, Yawen Wang, Yawen Wang, Yawen Wang, Qiwen Feng, Qiwen Feng, Qiwen Feng, Huanxin Zhang, Huanxin Zhang, Huanxin Zhang, Hai Cheng, Hai Cheng, Hai Cheng, Kunming Qi, Kunming Qi, Kunming Qi, Kailin Xu, Kailin Xu, Kailin Xu, Zhenyu Li, Zhenyu Li, Zhenyu Li   +26 more
doaj   +1 more source